Among all the traditional uses of frankincense, its anti-inflammatory properties have attracted the most scientific attention. Hundreds of studies have investigated how compounds in frankincense affect inflammation — and the results are genuinely promising. Here is what the research actually shows.
How boswellic acids fight inflammation
The primary active compounds in frankincense are boswellic acids — a family of pentacyclic triterpenes unique to Boswellia resin. The most potent of these is AKBA (3-O-acetyl-11-keto-beta-boswellic acid). Boswellic acids work by inhibiting 5-lipoxygenase (5-LOX), an enzyme that produces leukotrienes — inflammatory molecules involved in conditions ranging from arthritis to asthma.
This mechanism is significant because most conventional anti-inflammatory drugs (NSAIDs) target the COX pathway rather than the LOX pathway. Frankincense addresses a different branch of the inflammatory cascade, which is why researchers have found it can complement conventional treatments and, in some cases, work where NSAIDs alone fall short.
Clinical evidence for osteoarthritis
Multiple clinical trials have tested frankincense extracts in patients with osteoarthritis. In one well-known study, participants taking 1 gram of frankincense extract daily for 8 weeks reported significantly less joint swelling, less pain, better range of motion, and greater walking distance compared to the placebo group. Similar results have been replicated across several studies using different Boswellia preparations.
A systematic review of randomized controlled trials concluded that Boswellia extracts showed statistically and clinically significant improvements in pain and physical function for osteoarthritis patients. The evidence quality was rated as moderate — strong enough to be meaningful but with researchers calling for larger trials.
Rheumatoid arthritis
Research on frankincense for rheumatoid arthritis is more limited but still encouraging. Because RA involves a different inflammatory pathway (autoimmune-driven), the mechanisms are more complex. However, some studies have shown that boswellic acids can modulate the immune response in ways that may benefit RA patients, reducing both inflammatory markers and subjective pain scores.
Beyond joints: other inflammatory conditions
The anti-inflammatory action of boswellic acids is not limited to joints. Research has shown potential benefits for inflammatory bowel conditions, asthma and respiratory inflammation, skin conditions including psoriasis and eczema, and post-exercise muscle inflammation. The breadth of potential applications reflects the fundamental nature of the 5-LOX pathway in human inflammation.
How to use frankincense for inflammation
For joint and inflammatory conditions, frankincense is most commonly used as an oral supplement (standardized Boswellia serrata extract), topical essential oil (diluted and applied to affected areas), or aromatic resin (burned for respiratory and general systemic effects). For supplementation, look for products standardized to contain a specific percentage of boswellic acids — typically 60-65 percent. Consult with a healthcare provider before starting any supplement regimen, especially if you take other medications.
For topical use, frankincense essential oil from Boswellia sacra — diluted in a carrier oil — can be massaged into affected joints for localized relief. The anti-inflammatory compounds absorb through the skin and act locally.
Looking for pure Boswellia sacra oil from Oman? Shop our essential oil →